LAS VEGAS, NV--(Marketwired - Mar 14, 2016) - Alkame Holdings, Inc. (OTC: ALKM), a publicly traded health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly products, is pleased to announce positive results in Aquaculture farming using its patented water treatment technology.
Alkame Holdings Inc. teamed up with Keeton Industries, Seaworth Farms, Alpine Aquaculture and Wellington Operating Company, and constructed a research system in Wellington, Colorado and studied the effects of Alkame's patented technology when applied to intensive recirculating aquaculture systems. The research was conducted with Tilapia, and according to Wikipedia, Tilapia is currently the fourth most popular type of fish behind tuna, salmon and Alaskan Pollock, and the third most popular aquaculture or farm raised seafood product behind shrimp and salmon globally. More than 80 nations produce and farm tilapia, including the United States. The US produces 10 thousand tons of Tilapia against a consumption of 2.5 million, with Americans consuming over 1 pound of tilapia per person each year. Farmed tilapia production is about 1.5 million tons annually, with an estimated value of $1.8 billion (USD), about equal to that of salmon and trout.
Testing of the Alkame Technology is led by scientist and consulting biologist, Jim Keeton, a proven expert in this field. Jim Keeton and Keeton Industries has remained at the forefront of developing aquatic technology for successful fish farming, and has actively been involved in experimentation, design and manufacture of various components and equipment of sustainable design and engineering of intensive aquaculture systems, operations, and manufacturing solutions, with more than 40 years of experience.
"The major advantage of Alkame technology is that it can completely or partially destroy organics in water by converting them into various harmless intermediates and end products," stated lead scientist Jim Keeton. "Alkame's advanced system and design ensures that high concentrations of dissolved oxidants are released to the water when circulated across the cells, reducing Nitrites by 50 %. Clarity and solids were also substantially reduced from 4 inches to over 20 inches after oxidation within 48 hours. Tannins and Lignin's from feed leaching were removed with the Alkame process along with organic solids creating clearer and healthier water conditions. These factors could substantially reduce the size and costs of bio-filtration design for intensive recirculation systems."
"Our studies show that the Alkame Technology aids in the overall health of the water, which in turn creates a healthier environment to raise the fish. The Tilapia benefit by lowering the mortality rate (less than 2% mortality), accelerating growth (1 gram to about 38 to 50 grams in less than 60 days), and by reducing the size and cost to the bottom line of bio-filtration efficiency. Producing a cleaner healthier water for the Tilapia is a game changer for Aquaculture systems, and the industry as a whole worldwide," stated Alkame CEO, Robert Eakle. "After many months of research, and gathering up all of this encouraging hard analytical data, we can now begin to move towards exploiting our technology in this massive industry through various partnerships and joint ventures or licensing arrangements. We are very much looking forward to the pursuit of this application for our IP," Eakle added.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries market and distribute enhanced waters utilizing an exclusive patented formula and technology to create water with several unique properties, enabling an increase to available oxygen content, optimized pH levels, as well as the added benefits of electrolytes, and enhancement of antioxidant properties, equating into many potential health benefits, such as a reduced structure for permeability, improved metabolic efficiency, a boosted immune system, improved cardio respiratory function, and a decrease in lactic acid for faster muscle recovery. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, as well as many other various water treatment solutions to both new and existing business platforms.
For more information, visit www.alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.